Skip to main content
Clinical Trials/NCT02377830
NCT02377830
Completed
Phase 2

CYCLE Pilot: A Pilot Randomized Study of Early Cycle Ergometry Versus Routine Physiotherapy in Mechanically Ventilated Patients

McMaster University9 sites in 3 countries113 target enrollmentMarch 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Intensive Care Unit Acquired Weakness
Sponsor
McMaster University
Enrollment
113
Locations
9
Primary Endpoint
Patient accrual
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Background: Patients in the intensive care unit (ICU) are the sickest in hospital, and need advanced life-support. Survivors of critical illness are very weak and disabled. Up to 1 in 4 have severe leg weakness impairing their quality of life for as long as 5 years after ICU discharge. In-bed cycling involves use of special equipment that attaches to a patient's hospital bed, allowing them gentle exercise while in the ICU.

Methods: Adult patients admitted to the ICU who need a breathing machine and are expected to survive their ICU stay are eligible. Patients will randomly receive 30 minutes of in-bed cycling each day they are in the ICU or routine physiotherapy, both delivered by specially trained physiotherapists.

Outcomes: Feasibility: The investigators will study whether patients can cycle on most days of their ICU stay, whether patients and their families agree to be a part of the study, and whether investigators can systematically assess patients' strength.

Relevance: Effective methods of physiotherapy are needed for critically ill patients to minimize muscle weakness, speed recovery, and improve quality of life. This pilot randomized study is the second of several future larger studies about in-bed cycling in the ICU.

Our pilot work includes CYCLE Pilot and CYCLE Vanguard. CYCLE Pilot is an external pilot and enrolled 66 patients from 3/2015 to 6/2016. CYCLE Vanguard is an internal pilot and enrolled 47 patients from 11/2016 to 3/2018. CYCLE Vanguard patients will be analyzed in the main CYCLE RCT (NCT03471247).

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
December 2018
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults admitted to a medical-surgical ICU within the 1st 4 days of mechanical ventilation (MV) and 1st 7 days of ICU, and
  • could ambulate independently before hospital admission.

Exclusion Criteria

  • Acute condition impairing patients' ability to cycle (e.g., leg fracture),
  • proven or suspected neuromuscular weakness affecting the legs (e.g., stroke or Guillain-Barré syndrome),
  • unable to follow commands in English pre-ICU,
  • temporary pacemaker,
  • expected hospital mortality \>90%,
  • unable to fit the bike, palliative goals of care, or persistent therapy exemptions in the 1st 4 days of MV (e.g., cardiorespiratory instability, active major bleeding)

Outcomes

Primary Outcomes

Patient accrual

Time Frame: 2 years

Secondary Outcomes

  • Outcome measure ascertainment (% outcomes measured in hospital)(2 years)
  • Muscle strength at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only), and hospital discharge(From study admission to approximately 5, 12, 15 and 30 days, on average, respectively)
  • Cycling protocol violations (% cycling protocol violations)(2 years)
  • Quadriceps strength at ICU and hospital discharge (Force measured in Kg and in Newtons on a continuous scale)(From study admission to approximately 12 and 30 days, on average, respectively)
  • Blinded outcome measures at hospital discharge (% outcomes at hospital discharge measured by blinded outcome assessors)(2 years)
  • Physical Function Test for ICU (PFIT) at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only) and hospital discharge(From study admission to approximately 5, 12, 15 and 30 days, on average, respectively)
  • 2 minute walk test at ICU discharge, 3-days post-ICU (CYCLE Vanguard only), and hospital discharge(From study admission to approximately 12 and 30 days, on average, respectively)

Study Sites (9)

Loading locations...

Similar Trials